Day 1

Qué mas que la Angiografía es Necesario para Optimizar mis Resultados?

solaci
solaci
404
0

11_pichard_augusto
Augusto Pichard
2014-08-07

Director Innovation and Structural Heart Disease,  Vice Chair, Medstar Heart Institute, 
Medstar Washington Hospital Center. Professor of Medicine (Cardiology),
Georgetown University Medical School.

Previous article
¿Cómo llevar mi Servicio a un 95% radial?
Next article
Hemoducto Venoso: Cambio en el Paradigma de Tratamiento
solaci
solaci

More articles by this author

Nuevas Estrategias de Reperfusión Miocárdica en el IAM con Elevación del Segmento ST

solaci - 0
José Mangione2014-08-07

Prevención y Manejo de dificultades en la via radial

solaci - 0
Pablo Vázquez Grenno 2014-08-07Sanatorio Americano. CCAMontevideo. Uruguay

Caso Clinico

solaci - 0
Alfaro Marchena Noriega2014-08-07Vicepresidente Sociedad Panameña de CardiologíaPresidente Fundación Cardiológica de Panamá

Chronic Total Occlusions

solaci - 0
Luis A Guzman2014-08-07Director, Cardiovascular InterventionsUniversity of Florida-Jacksonville

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACC 2026 | ALL-RISE Trial: Coronary Physiological Assessment Using FFRangio

Dr. Juan Manuel Pérez - 0
Coronary physiological assessment using pressure-wire techniques (FFR/iFR) carries a Class IA recommendation in ACC/AHA guidelines; however, its use remains limited due to factors such...

ACC 2026 | Protect The Head-To-Head Trial: Randomized Comparison Between Emboliner and Sentinel During TAVI

Dr. Juan Manuel Pérez - 0
Ischemic stroke remains one of the most feared complications of TAVI, with a relatively low but persistent incidence of 2–4%, without significant reduction over...

ACC 2026 | PRO-TAVI Trial: Deferring Coronary Angioplasty in Patients Undergoing TAVI

Dr. Juan Manuel Pérez - 0
Coronary artery disease is common in patients with severe aortic stenosis undergoing TAVI. Current guidelines recommend considering revascularization in significant coronary lesions, particularly in...